jag009
★★★

NJ,
2012-04-17 23:42
(5187 d 20:19 ago)

Posting: # 8437
Views: 3,303
 

 BE study design question [Design Issues]

Hi everyone,

If a product is labeled as "can be chewed or swallowed as a tablet". The generic BE program should include two SD studies:

1) Test (swallowed) vs Ref (swallowed)
2) Test: Chewed vs Swallowed

Correct?

Thanks

John
CLR
☆    

Singapore,
2012-04-18 08:29
(5187 d 11:32 ago)

@ jag009
Posting: # 8438
Views: 2,816
 

 BE study design question

Hi John,

I think an SD study for swallowed dosing will suffice. For example, the FDA's product-specific guidance for montelukast chewable tablets (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm088707.pdf) states that the tablet should be swallowed whole - this would ensure the standardised delivery of the dose, as opposed to variability introduced during chewing.

Perhaps other more experienced members of this forum will be able to lend more insight

Clare
jag009
★★★

NJ,
2012-04-18 17:21
(5187 d 02:39 ago)

@ CLR
Posting: # 8441
Views: 2,719
 

 BE study design question

❝ Hi John,


❝ I think an SD study for swallowed dosing will suffice. For example, the FDA's product-specific guidance for montelukast chewable tablets (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm088707.pdf) states that the tablet should be swallowed whole - this would ensure the standardised delivery of the dose, as opposed to variability introduced during chewing.

.
.

Thanks Clare
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
342 visitors (0 registered, 342 guests [including 9 identified bots]).
Forum time: 20:01 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5